NCT03197376View on ClinicalTrials.gov

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

2,250

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

June 6, 2018

Study Completion Date

May 9, 2019

Conditions
Pneumonia, Pneumococcal
Interventions
BIOLOGICAL

Pneumosil

10-Valent Pneumococcal Conjugate Vaccine

BIOLOGICAL

Synflorix

Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed

Trial Locations (1)

Unknown

Medical Research Council (MRC) Unit, The Gambia, Fajara

All Listed Sponsors
lead

PATH

OTHER

NCT03197376 - Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants | Biotech Hunter | Biotech Hunter